NCT07905651Not yet recruiting
Effects of Paraffin Wax Therapy and Dry Cupping on Pain and Wrist Function in Patients With Rheumatoid Arthritis
The Effect of Paraffin Wax Therapy and Dry Cupping on Pain Intensity and Wrist Joint Functional Performance For Patients With Rheumatoid Arthritis
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
Rheumatoid arthritis is a chronic inflammatory disease that can cause pain, stiffness, and reduced functional performance in the wrist and hand joints. These problems may make daily activities, such as gripping objects and performing self-care tasks, more difficult. The purpose of this study is to evaluate the effects of paraffin wax therapy and dry cupping on pain intensity and wrist joint functional performance among patients with rheumatoid arthritis. The study will compare two groups: one receiving paraffin wax therapy and the other receiving dry cupping therapy Pain intensity and wrist joint functional performance will be assessed before and after the interventions using standardized assessment tools. The findings may help determine whether these complementary therapies can reduce pain and improve wrist function in patients with rheumatoid arthritis.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 23 Oct 2026
- Start date
- 25 Oct 2026
- Primary completion date
- 26 Nov 2026
- Lead sponsor
- University of Baghdad
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07905651
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 25 Oct 2026 to the primary completion date, 26 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe deformities or surgery involving the hands or upper back within the previous 6 months.
- Previous experience with paraffin wax therapy or cupping therapy within the past 6 months.
Other illness
- Acute joint inflammation or infection in the hands or upper back at the time of screening.
- Skin lesions, open wounds, infections, skin fragility, or severe vascular disease (e.g., deep vein thrombosis or severe varicose veins) at the proposed treatment sites.
- Significant comorbidities, including uncontrolled diabetes mellitus, renal failure, polycythemia vera, active malignancy, severe cardiovascular or respiratory disease, or coagulopathies, or current use of anticoagulants.
- Known hypersensitivity to paraffin wax or materials used in cupping (e.g., acrylic or silicone).
Other
- Pregnancy or lactation.
Who the study is looking for
- Age 20-60 years.
- Diagnosis of rheumatoid arthritis (RA) fulfilling the 2010 ACR/EULAR classification criteria.
- Seropositive for rheumatoid factor (RF).
- Stable regimen of conventional RA medications for at least 3 months before enrollment, including non-steroidal anti-inflammatory drugs (NSAIDs), conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), and/or biologic disease-modifying anti-rheumatic drugs (bDMARDs), with agreement to maintain the same regimen throughout the study period.
Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rheumatology Clinic at Baghdad Teaching Hospital in Baghdad city Coordinator of this site? Confirm its status | Baghdad | Iraq | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.